nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
|
Cai, Shaozhe |
|
|
39 |
9 |
p. 2797-2802 |
artikel |
2 |
Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature review
|
Abisror, Noémie |
|
|
39 |
9 |
p. 2707-2713 |
artikel |
3 |
A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome
|
Behrens Pinto, Gustavo Luiz |
|
|
39 |
9 |
p. 2763-2771 |
artikel |
4 |
Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus
|
Zeng, Yanli |
|
|
39 |
9 |
p. 2619-2629 |
artikel |
5 |
Association between comorbidities and extraglandular manifestations in primary Sjögren’s syndrome: a multicenter cross-sectional study
|
Zhang, Yuying |
|
|
39 |
9 |
p. 2677-2688 |
artikel |
6 |
Cancer risks along the disease trajectory in antineutrophil cytoplasmic antibody associated vasculitis
|
Thet, Zaw |
|
|
39 |
9 |
p. 2501-2513 |
artikel |
7 |
Challenges in delivering rheumatology care during COVID-19 pandemic
|
Nune, A. |
|
|
39 |
9 |
p. 2817-2821 |
artikel |
8 |
Clinical features of Behcet’s disease in Mongolia: a multicenter study
|
Balt, Javzandulam |
|
|
39 |
9 |
p. 2697-2706 |
artikel |
9 |
Coexistence of antiphospholipid syndrome and cryoglobulinemia in a patient with rheumatoid arthritis
|
Cajiao, Katherine |
|
|
39 |
9 |
p. 2833-2835 |
artikel |
10 |
Comment on “Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases”
|
Zhao, Shu-Shan |
|
|
39 |
9 |
p. 2841-2842 |
artikel |
11 |
Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology
|
Mantovani Cardoso, Eduardo |
|
|
39 |
9 |
p. 2811-2815 |
artikel |
12 |
Correction to: Mortality burden associated with all-cause pneumonia among adults with autoimmune inflammatory rheumatic diseases, human immunodeficiency virus infection, and malignancies: a population-based comparative study for informed decision-making in public health policies
|
de Rezende, Rodrigo Poubel Vieira |
|
|
39 |
9 |
p. 2843-2844 |
artikel |
13 |
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
|
Santos, C. Sieiro |
|
|
39 |
9 |
p. 2789-2796 |
artikel |
14 |
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-
|
Ebina, Kosuke |
|
|
39 |
9 |
p. 2563-2572 |
artikel |
15 |
Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis
|
Zhang, Fangze |
|
|
39 |
9 |
p. 2653-2661 |
artikel |
16 |
Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases
|
Bao, Yanfeng |
|
|
39 |
9 |
p. 2523-2528 |
artikel |
17 |
Early onset primary Sjögren syndrome, clinical and laboratory characteristics
|
Yayla, Müçteba Enes |
|
|
39 |
9 |
p. 2689-2696 |
artikel |
18 |
Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT
|
Stouten, Veerle |
|
|
39 |
9 |
p. 2593-2601 |
artikel |
19 |
Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring
|
Candemir, Mustafa |
|
|
39 |
9 |
p. 2631-2639 |
artikel |
20 |
Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study
|
Richi, Patricia |
|
|
39 |
9 |
p. 2751-2756 |
artikel |
21 |
FDG PET/CT used in identifying adult-onset Still’s disease in connective tissue diseases
|
Zhou, Xin |
|
|
39 |
9 |
p. 2735-2742 |
artikel |
22 |
Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα
|
Nguyen, Minh Vu Chuong |
|
|
39 |
9 |
p. 2553-2562 |
artikel |
23 |
18F-FDG PET/CT in bone sarcoidosis: an observational study
|
Demaria, Lucie |
|
|
39 |
9 |
p. 2727-2734 |
artikel |
24 |
Founder effects of the homogentisate 1,2-dioxygenase (HGD) gene in a gypsy population and mutation spectrum in the gene among alkaptonuria patients from India
|
Danda, Sumita |
|
|
39 |
9 |
p. 2743-2749 |
artikel |
25 |
Full histological and clinical regression of morphea with tofacitinib
|
Scheinberg, Morton |
|
|
39 |
9 |
p. 2827-2828 |
artikel |
26 |
Good response to mycophenolate mofetil on treatment of interstitial lung disease in polymyositis associated with antisynthetase syndrome positive for anti-EJ and anti-Ro52 antibodies
|
Martínez-García, Erika A. |
|
|
39 |
9 |
p. 2837-2839 |
artikel |
27 |
Human immunodeficiency virus infection (HIV)–associated rheumatic manifestations in thepre- and post-HAART eras
|
Vega, Luis E. |
|
|
39 |
9 |
p. 2515-2522 |
artikel |
28 |
Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis
|
Haque, Ashraful |
|
|
39 |
9 |
p. 2823-2824 |
artikel |
29 |
Microangiopathy and forearm arterial blood flow in systemic sclerosis: a controlled study
|
Bieber, Amir |
|
|
39 |
9 |
p. 2671-2676 |
artikel |
30 |
Persistent chikungunya arthritis in Roraima, Brazil
|
Hayd, Ramão Luciano Nogueira |
|
|
39 |
9 |
p. 2781-2787 |
artikel |
31 |
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
|
Bird, Paul |
|
|
39 |
9 |
p. 2545-2551 |
artikel |
32 |
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting
|
Navarini, Luca |
|
|
39 |
9 |
p. 2663-2670 |
artikel |
33 |
Rheumatoid arthritis and myelodysplastic syndrome: a fortuitous association?
|
El Ouali, Zakaria |
|
|
39 |
9 |
p. 2829-2831 |
artikel |
34 |
Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan
|
Chen, Hung-Yi |
|
|
39 |
9 |
p. 2773-2780 |
artikel |
35 |
Sclerochoroidal calcifications associated with early-onset calcium pyrophosphate deposition disease
|
Ciaffi, Jacopo |
|
|
39 |
9 |
p. 2825-2826 |
artikel |
36 |
Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren’s syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis
|
Hammam, Nevin |
|
|
39 |
9 |
p. 2603-2610 |
artikel |
37 |
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review
|
He, Feng |
|
|
39 |
9 |
p. 2803-2810 |
artikel |
38 |
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study
|
Behrens, Frank |
|
|
39 |
9 |
p. 2583-2592 |
artikel |
39 |
Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India
|
Shenoy, Padmanabha |
|
|
39 |
9 |
p. 2757-2762 |
artikel |
40 |
Syndemic and syndemogenesis of low back pain in Latin-American population: a network and cluster analysis
|
Strozzi, Alfonso Gastelum |
|
|
39 |
9 |
p. 2715-2726 |
artikel |
41 |
The changing profile of ankylosing spondylitis in the biologic era
|
Reveille, John D. |
|
|
39 |
9 |
p. 2641-2651 |
artikel |
42 |
The decreased expression of IKBKE in systemic lupus erythematosus
|
Zhu, Tingting |
|
|
39 |
9 |
p. 2611-2617 |
artikel |
43 |
The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs
|
Zhao, Juan |
|
|
39 |
9 |
p. 2573-2581 |
artikel |
44 |
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
|
Ahmed, Sakir |
|
|
39 |
9 |
p. 2529-2543 |
artikel |